![SMFM's Podcast Series show](https://d3dthqtvwic6y7.cloudfront.net/podcast-covers/000/092/624/small/smfm-s-podcast-series.png)
Summary: Dr. Mandelbrodt discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii. The results were presented at the SMFM Annual Pregnancy Meeting in February 2018.